Muscular Dystrophy: Pathogenesis and Therapies

The summary for the Muscular Dystrophy: Pathogenesis and Therapies grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Muscular Dystrophy: Pathogenesis and Therapies: - The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), the National Institute of Neurological Disorders and Stroke (NINDS), the National Institute of Child Health and Human Development (NICHD) and the National Heart, Lung, and Blood Institute (NHLBI) encourage investigator-initiated research grant applications for projects studying pathogenesis and therapies for the muscular dystrophies. Responses to this announcement may include basic, translational or patient-oriented studies of Duchenne/Becker muscular dystrophy, facioscapulohumeral dystrophy, myotonic dystrophy or other forms of muscular dystrophy. - This PA will use the NIH Exploratory/Developmental Research Grant Award (R21) and the NIH Research Project Grant Award (R01) mechanisms. R21 applications may request up to $275,000 direct costs for the two-year term of the grant. There is no cost limit for the R01 mechanism, however applicants requesting $500,000 or more in direct costs for any year must obtain an agreement that one of the participating institutes will accept your application for consideration for review and possible award. To obtain this agreement, contact the appropriate IC program staff (listed in Section VII. below) at least 6 weeks prior to the application receipt date (8 weeks for NICHD and approximately 18 weeks for NIAMS). Please refer to NIAMS policy on applications requesting $500,000 or more per year in direct costs http://www.niams.nih.gov/rtac/grantapps/guidelines.htm. - The number of awards and the total amount to be awarded will depend on the number and quality of the applications received and the Institutes' availability of funds. - Eligible organizations include for-profit and non-profit organizations, public or private institutions such as universities, colleges, hospitals and laboratories, units of State and local governments, eligible agencies of the Federal government, domestic or foreign institutions/organizations. - Eligible principal investigators include any individuals with the skills, knowledge, and resources necessary to carry out the proposed research. - There is no limit on the number of scientifically different applications that may be submitted. - Application materials and instructions are available at: http://grants.nih.gov/grants/funding/phs398/phs398.html- Telecommunications for the hearing impaired is available at: TTY 301-451-0088